Patient Journey to Alzheimer's Disease Treatment
Wednesday, December 6, 2023 at 2-3 pm ET Pricing: Free for Members and Non-Members
Please note that this session is not accredited for continuing pharmacy education credit.
Alzheimer's disease (AD) is a growing public health crisis and represents a crucial unmet need in healthcare. New AD diagnostic tools and therapies are evolving the management of AD, changing the patient journey towards earlier identification and treatment initiation.
During this program, we will overview the patient journey to treatment and discuss signs and diagnosis of early AD, the clinical trial data in informing selection for treatment for appropriate patients, key considerations for initiating the treatment, and monitoring for safety.
This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.
For individuals from the media/press interested in attending, please email firstname.lastname@example.org.
Christine Divers, PhD
Director, U.S. Field Health & Economics & Outcomes Research and Real World Evidence